133 related articles for article (PubMed ID: 203383)
1. Metabolism and intracellular retention of 1-beta-D-arabinofuranosylcytosine as predictors of response of animal tumors.
Rustum YM
Cancer Res; 1978 Mar; 38(3):543-9. PubMed ID: 203383
[No Abstract] [Full Text] [Related]
2. Formation of 1-beta-D-arabinofuranosylcytosine diphosphate choline in neoplastic and normal cells.
Lauzon GJ; Paterson AR; Belch AW
Cancer Res; 1978 Jun; 38(6):1730-3. PubMed ID: 274175
[TBL] [Abstract][Full Text] [Related]
3. Formulation, stability, and antitumor activity of 1-beta-D-arabinofuranosylcytosine conjugate of thioether phospholipid.
Hong CI; Bernacki RJ; Hui SW; Rustum Y; West CR
Cancer Res; 1990 Jul; 50(14):4401-6. PubMed ID: 2364392
[TBL] [Abstract][Full Text] [Related]
4. Transport and metabolism of deoxycytidine and 1-beta-D-arabinofuranosylcytosine into cultured Novikoff rat hepatoma cells, relationship to phosphorylation, and regulation of triphosphate synthesis.
Plagemann PG; Marz R; Wohlhueter RM
Cancer Res; 1978 Apr; 38(4):978-89. PubMed ID: 205355
[No Abstract] [Full Text] [Related]
5. Antileukemic activity of 1-beta-D-arabinofuranosyl-2-amino-1,4(2H)-4-iminopyrimidine, a new depot form of 1-beta-D-arabinofuranosylcytosine.
Khwaja TA; Kigwana LJ; Mian AM
Cancer Res; 1979 Aug; 39(8):3129-33. PubMed ID: 455296
[No Abstract] [Full Text] [Related]
6. Metabolism and selective effects of 1-beta-D-arabinofuranosylcytosine in L1210 and Host tissues in vivo.
Chou TC; Hutchinson DJ; Schmid FA; Philips FS
Cancer Res; 1975 Jan; 35(1):225-36. PubMed ID: 1109791
[TBL] [Abstract][Full Text] [Related]
7. Deoxycytidine kinase. I. Distribution in normal and neoplastic tissues and interrelationships of deoxycytidine and 1-beta-D-arabinofuranosylcytosine phosphorylation.
Durham JP; Ives DH
Mol Pharmacol; 1969 Jul; 5(4):358-75. PubMed ID: 4308509
[No Abstract] [Full Text] [Related]
8. Pharmacokinetics and cellular determinants of response to 1-beta-arabinofuranosylcytosine (ara-C).
Riva CM; Rustum YM; Preisler HD
Semin Oncol; 1985 Jun; 12(2 Suppl 3):1-8. PubMed ID: 3859925
[No Abstract] [Full Text] [Related]
9. Antitumor effect and mode of action of 1-beta-D-arabinofuranosylcytosine 5'-phosphate in leukemia L1210.
Schrecker AW; Goldin A
Cancer Res; 1968 Apr; 28(4):802-3. PubMed ID: 5649067
[No Abstract] [Full Text] [Related]
10. Studies on the accumulation mechanisms of 67 Ga in tumors: role of calcium metabolism.
Anghileri LJ
Strahlentherapie; 1972 Jul; 144(1):29-34. PubMed ID: 4342978
[No Abstract] [Full Text] [Related]
11. 1-beta-D-arabinofuranosylcytosine metabolism and incorporation into DNA as determinants of in vivo murine tumor cell response.
Riva CM; Rustum YM
Cancer Res; 1985 Dec; 45(12 Pt 1):6244-9. PubMed ID: 2998596
[TBL] [Abstract][Full Text] [Related]
12. Production of N4-succinyl-1-beta-D-arabinofuranosylcytosine, a novel metabolite of N4-behenoyl-1-beta-D-arabinofuranosylcytosine, in mice and its biological significance.
Oh-ishi J; Kataoka T; Tsukagoshi S; Sakurai Y; Shibukawa M; Kobayashi H
Cancer Res; 1981 Jun; 41(6):2501-6. PubMed ID: 7237444
[TBL] [Abstract][Full Text] [Related]
13. N4-Behenoyl-1-beta-D-arabinofuranosylcytosine as a potential new antitumor agent.
Aoshima M; Tsukagoshi S; Sakurai Y; Oh-ishi JI; Ishida T
Cancer Res; 1977 Aug; 37(8 Pt 1):2481-6. PubMed ID: 872077
[TBL] [Abstract][Full Text] [Related]
14. Formation of 1-beta-D-arabinofuranosylcytosine diphosphate choline in cultured human leukemic RPMI 6410 cells.
Lauzon GJ; Paran JH; Paterson AR
Cancer Res; 1978 Jun; 38(6):1723-9. PubMed ID: 274174
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and structure-activity studies in vivo of liposomal phospholipid-N4-palmitoyl- and N4-hexadecyl-1-beta-D-arabinofuranosylcytosine conjugates.
Schott H; Schwendener RA
Anticancer Drug Des; 1996 Sep; 11(6):451-62. PubMed ID: 8836110
[TBL] [Abstract][Full Text] [Related]
16. Metabolism of 1-beta-D-arabinofuranosylcytosine in leukemia L1210: studies with intact cells.
Shrecker AW; Urshel MJ
Cancer Res; 1968 Apr; 28(4):793-801. PubMed ID: 5649066
[No Abstract] [Full Text] [Related]
17. Antitumor effects and pharmacology of orally administered N4-palmitoyl-1-beta-D-arabinofuranosylcytosine in mice.
Hori K; Tsuruo T; Naganuma K; Tsukagoshi S; Sakurai Y
Cancer Res; 1984 Jan; 44(1):172-7. PubMed ID: 6690034
[TBL] [Abstract][Full Text] [Related]
18. Report from Sloan-Kettering Institute. Enzyme therapy and nutritional depletion of tumors.
Clin Bull; 1974; 4(2):74-6. PubMed ID: 4370337
[No Abstract] [Full Text] [Related]
19. Metabolism of 1-beta-D-arabinofuranosylcytosine in leukemia L1210: nucleoside and nucleotide kinases in cell-free extracts.
Schrecker AW
Cancer Res; 1970 Mar; 30(3):632-41. PubMed ID: 5425288
[No Abstract] [Full Text] [Related]
20. Modulation of the metabolism and pharmacokinetics of 1-beta-D-arabinofuranosylcytosine by 1-beta-D-arabinofuranosyluracil in leukemic mice.
Chandrasekaran B; Capizzi RL; Kute TE; Morgan T; Dimling J
Cancer Res; 1989 Jun; 49(12):3259-66. PubMed ID: 2720678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]